Hirsutism
hirsutism · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Excess terminal hair in a male pattern in women, usually from androgen excess or increased follicular sensitivity. Most cases are PCOS; the priority is excluding rare sinister androgen sources.
Red flags
- Rapid onset or progression over months
- Signs of virilisation (clitoromegaly, voice change, male-pattern balding)
- Testosterone markedly elevated (tumour threshold)
- Features of Cushing syndrome
- Palpable pelvic/abdominal mass
Assessment
Differential diagnosis
- Polycystic ovary syndrome
- Idiopathic hirsutism
- Non-classic congenital adrenal hyperplasia
- Androgen-secreting ovarian/adrenal tumour
- Cushing syndrome
- Drug-induced hypertrichosis
Investigations
- Total and free testosterone
- DHEAS and 17-hydroxyprogesterone
- SHBG, LH/FSH and prolactin
- Pelvic ultrasound
- 1 mg dexamethasone suppression test if Cushing suspected
Management
- Quantify severity (e.g. Ferriman-Gallwey) and assess rate of onset
- Screen for red flags of tumour: rapid onset, virilisation, very high androgens
- Measure morning testosterone and relevant androgens
- Exclude non-classic CAH with 17-hydroxyprogesterone and Cushing if clinically suggested
- Start cosmetic/mechanical measures and discuss realistic timelines (3-6 months)
- Use combined oral contraceptive as first-line pharmacotherapy
- Add an antiandrogen if inadequate after 6 months (with reliable contraception)
- Offer topical eflornithine for facial hair
- Investigate urgently if androgen-secreting tumour is suspected
Drugs & doses
Combined oral contraceptive (ethinylestradiol with drospirenone/cyproterone) once daily
Spironolactone 50-100 mg PO twice daily
Finasteride 5 mg PO once daily (with contraception) or cyproterone acetate
Eflornithine 11.5% cream topically twice daily for facial hair
Disposition
Manage benign cases in primary care/gynaecology; refer suspected tumour or Cushing to endocrinology urgently for localisation and treatment.
Complications & pitfalls
- Psychological distress and reduced quality of life
- Missed androgen-secreting tumour
- Teratogenicity of antiandrogens without contraception
- Metabolic consequences of underlying PCOS
Exam pearls
- Rapid virilising hirsutism with high androgens signals a tumour until proven otherwise
- Combined oral contraceptive plus antiandrogen is the mainstay for benign cases
- Hair-growth cycles mean any treatment needs at least 6 months to judge
- Always pair antiandrogens with reliable contraception
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.